The Medtronic CareLink Network is the Internet-based remote monitoring service for patients with Medtronic implanted cardiac devices and their clinics.
Using a standard phone line, patients can send their device information to their clinics from the comfort of their home or while traveling.
The monitor plugs into a standard phone line, gathers the information and sends it to a secure storage site. The Internet is not needed to transmit.

The LATITUDE Patient Management System by Boston Scientific has FDA approval to be used in virtually all of the company's implantable defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). This approval increases the number of patients eligible to receive the benefits of home monitoring by more than 150,000 in the U.S.

The AfibAlert Atrial Fibrillation Monitor is a healthcare provider-prescribed ambulatory cardiac monitor for improved atrial fibrillation management. The pocket-sized monitor is a tool for the more than two million Americans who suffer from atrial fibrillation.

The NaviStar ThermoCool Catheter is available for the treatment of adults with specific rapid heartbeats who have already experienced failure with other treatments, such as device or other antiarrhythmic drug therapy. These specific rapid heartbeats are scientifically known as ventricular tachycardia (VT) that arise following a heart attack. The catheter is the first FDA-approved catheter to treat both mappable and unmappable VTs. The expanded indication provides cardiac electrophysiologists with a new treatment option for the estimated three million people in the U.S.

Developed to help hospitals seamlessly bring their entire portfolio of wireless services and applications together on a single infrastructure, Enterprise Access with Wireless Medical Telemetry Service (WMTS) enables healthcare organizations to harness the power of next-generation wireless computing throughout their facilities.

HeartCentrix is a software solution that enables Burdick and Quinton stress, Holter and ECG devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems. Cardiac Science owns the Burdick and Quinton brands.

The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the world, including countries in Western and Eastern Europe, Asia Pacific and the Middle East. Cordis Corp. expects to offer the CYPHER SELECT Plus Stent in most markets outside the U.S. and Japan within the next two quarters.

The AngioJet SpiroflexVG Rheolytic Thrombectomy catheter is the first AngioJet catheter of its size to be offered in a Rapid Exchange platform.
Utilizing its proprietary Spiroflex shaft technology, the Spiroflex VG catheter benefits from several design improvements made to the most recent generation of Possis Medical products. The catheter offers improved trackability inside the vessel and includes tip and hub improvements found on the recently introduced Spiroflex catheter. The Spiroflex VG Catheter is fully released for sale in the U.S. for peripheral use.

With several integrated cardiac features, CARESTREAM PACS includes cardiac review and analysis, cardiac cage removal in 3-D imaging and cardiac calcium scoring.

The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe.
Embolic protection devices are designed to capture and remove particles of atherosclerotic plaque that can become dislodged during a carotid artery stenting procedure, potentially leading to stroke and other complications.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now